Caleb Tripp - 11 Aug 2025 Form 4 Insider Report for BridgeBio Oncology Therapeutics, Inc. (HLXB)

Signature
/s/ Caleb Tripp
Issuer symbol
HLXB
Transactions as of
11 Aug 2025
Net transactions value
$0
Form type
4
Filing time
11 Aug 2025, 17:05:55 UTC
Previous filing
09 Feb 2024
Next filing
22 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tripp Caleb Chief Financial Officer C/O HELIX ACQUISITION CORP. II, 200 CLARENDON STREET, 52ND FLOOR, BOSTON /s/ Caleb Tripp 11 Aug 2025 0002010981

Caleb Tripp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This is a voluntary "exit" report, filed solely to report that the Reporting Person is no longer the Issuer's Chief Financial Officer, effective as of August 11, 2025, and therefore is no longer subject to Section 16 reporting. The Reporting Person did not have any transactions in the Issuer's securities requiring disclosure in this voluntary "exit" report. No securities are beneficially owned.